People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. | — | Pharmaceuticals | Series B | $35.0M | $11.1M | 2021 |
HOONMO A LEE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside HOONMO A LEE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roger J. Pomerantz | 1 | 4 |
| JEFFREY A MECKLER | 1 | 3 |
| Robert E. Martell | 1 | 2 |
| Walt A. Linscott | 1 | 2 |
| William B. Hayes | 1 | 2 |
| BRIAN J. O'CALLAGHAN | 1 | 2 |
| Anthony J. Maddaluna | 1 | 2 |
| NIR A SASSI | 1 | 2 |
| MICHAEL A NEWMAN | 1 | 2 |
| HILA W. KARAH | 1 | 2 |
| Roger J. Waltzman | 1 | 2 |
| Michael J Newman | 1 | 2 |
| Mark J. Gilbert | 1 | 1 |
| Nir J Sassi | 1 | 1 |
| Hila J. Karah | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.